Sasi, S., Yassin, M.A., Kamran, S. and Mnatsakanyan, V. (2020) Association of Polycythemia Vera with Positive JAK2V617F Mutation and Myasthenia Gravis: A Report of Two Cases. Clinical Case Reports, 9, 531-534.
https://doi.org/10.1002/ccr3.3574

has been cited by the following article:

• TITLE: Post-Vaccination Myasthenia Gravis and Vaquez Disease

  AUTHORS: Alassane Mamadou Diop, Ahmadou Bamba Mbodj, Daouda Thioub, Jamil Kawahgi, Maouly Fall

  KEYWORDS: SARS-CoV2, Myasthenia, JAK2

  JOURNAL NAME: Neuroscience and Medicine, Vol.16 No.2, June 25, 2025

  ABSTRACT: We report the case of a 68-year-old patient who developed autoimmune myasthenia 24 hours after receiving the second dose of an inactivated SARS-CoV-2 vaccine (Sinopharm®). This patient, already followed for ischemic heart disease, presented with typical symptoms such as diplopia, bilateral ptosis, and muscle fatigability upon exertion. Investigations revealed the presence of anti-acetylcholine receptor antibodies as well as polycythemia, confirmed by the JAK2 V617F mutation, suggesting an association with a myeloproliferative disorder.